Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Prostate cancer
      • Bladder cancer
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • Media
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
    • Our annual accounts
    • Pelican Cancer Foundation – What next?
    • Support Us
    • Job opportunities
    • Partners
  • Workshops
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Videos
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Prostate Cancer Research
      • Focal therapy and HIFU research
      • MRI research for prostate cancer
      • Prostate cancer colloquiums
      • FORECAST
      • Trachtomap
      • Papers of interest
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Bladder cancer research
      • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Jay’s story (bladder cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Prostate cancer
      • Our prostate cancer team
      • Prostate cancer treatment options
      • Pelican’s position
    • Bladder cancer
      • Blue light cystoscopy
      • Bladder cancer – useful contacts
    • Pseudomyxoma peritonei
    • Kidney cancer
      • Our kidney cancer team
      • Kidney cancer – useful contacts
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Charity of the Year partnerships
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

Key messages from the faculty – TIPTOP

February 12, 2019 by pelicanadmin

Reducing timelines in a time of increased demands

  • To work collaboratively with all those involved in the pathway
  • Try and trim off time at each step of the pathway without compromising patient care

mpMRI and biopsy

  • Target the lesion, sample the other side
  • Once you are happy with your MRI/targeted biopsy pathway, allow men with a negative MRI and low PSA density to choose not to have standard biopsy
  • mpMRI is an effective, validated diagnostic tool in the detection of prostate cancer but, as a limited resource, should be used wisely and appropriately.
  • Urologists should refrain from undertaking routine transrectal biopsy in patients with a marginally raised PSA without considering all factors in the decision making process e.g. FHX, DRE findings, BRCA status, MRI findings and PSA density.
  • Transrectal biopsy is not without its morbidity and should not be used as a screening biopsy tool.

 Pathology in the pathway

  • Clinicians do not need knowledge of histology but must be able to interpret pathology report data correctly
  • Prostate biopsy report interpretation has several unique features. “Headline” figures may be misleading
  • Grade and stage are biological continuums with subjective cut-offs. In borderline cases, effective communication is more important than the accuracy of assigned grade/stage.

Patient’s perspective from the CNS

  • Consider what patients expect and require from the referral process and what constitutes a good patient experience
  • Understand the MRI, understand the patient, plan a strategy

 

Filed Under: Uncategorized

Pelican Cancer Foundation Follow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican_Cancer
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
15h

🎥The future challenges for colorectal cancer management
👇 Available to watch now - http://pelicancancervideos.org

Reply on Twitter 1557246868060520448 Retweet on Twitter 1557246868060520448 2 Like on Twitter 1557246868060520448 4 Twitter 1557246868060520448
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
9 Aug

👇 Available to watch now - http://pelicancancervideos.org
🎥The future challenges for colorectal cancer management

Fourth and final session with Prof Phil Quirke, Prof Heald and Mr Moran @Brendan92855812 @ProfessorHeald in our series Milestones in Managing and Curing Rectal Cancer.

Reply on Twitter 1556881711698325504 Retweet on Twitter 1556881711698325504 5 Like on Twitter 1556881711698325504 7 Twitter 1556881711698325504
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
4 Aug

Book now to attend the KHP Kent & Hampshire Hospitals NET Centre 9th Annual Meeting - discussing the management of patients with neuroendocrine tumours

Convened by Dr. Raj Srirajaskanthan & Professor John Ramage

14/10/2022, 10 - 5pm, London - SE5 8BB
http://netninthannualmeeting.eventbrite.co.uk

Reply on Twitter 1555070527651209217 Retweet on Twitter 1555070527651209217 1 Like on Twitter 1555070527651209217 1 Twitter 1555070527651209217
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2022 · Outreach Pro Theme on Genesis Framework · WordPress · Log in